CTRI Number |
CTRI/2022/04/042058 [Registered on: 22/04/2022] Trial Registered Prospectively |
Last Modified On: |
21/04/2022 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Biological Surgical/Anesthesia |
Study Design |
Randomized, Parallel Group Trial |
Public Title of Study
|
Comparison of platelet rich plasma and triamcinolone in patient of osteoarthritis of knee for pain relief. |
Scientific Title of Study
|
Comparision of the analgesic effect of intraarticular platelet rich plasma and triamcinolone in patient of osteoarthritis knee - randomized control trial |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Jankiben Panchal |
Designation |
First year resident anaesthesia |
Affiliation |
sir t hospital bhavanagar |
Address |
303 PG -3 hostel , Sir T Hospital,
4th floor, Department of Anaesthesia, GMC Bhavnagar 303 PG -3 hostel, Sir T Hospital,
4th floor, Department of Anaesthesia,
GMC Bhavnagar Bhavnagar GUJARAT 364001 India |
Phone |
6354517097 |
Fax |
|
Email |
panchaljanki222@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Lopa Trivedi |
Designation |
Assosciate Professor |
Affiliation |
Government Medical College, Bhavnagar |
Address |
4th floor, Department of Anaesthesia, GMC Bhavnagar. 4th floor, Department of Anaesthesia, GMC Bhavnagar. 364001 Bhavnagar GUJARAT 364001 India |
Phone |
6354517097 |
Fax |
|
Email |
trivedi_lopa@yahoo.in |
|
Details of Contact Person Public Query
|
Name |
Jankiben Panchal |
Designation |
First year resident anaesthesia |
Affiliation |
sir t hospital bhavanagar |
Address |
303 PG -3 hostel, Sir T hospital, Department of Anaesthesia, GMC Bhavnagar 303 PG -3 hostel, Sir T hospital, Department of Anaesthesia, GMC Bhavnagar. 364001 Bhavnagar GUJARAT 364001 India |
Phone |
6354517097 |
Fax |
|
Email |
panchaljanki222@gmail.com |
|
Source of Monetary or Material Support
|
anesthesia department Sir T government hospital bhavnagr 364001 |
|
Primary Sponsor
|
Name |
Government medical college bhavnagr |
Address |
Government medical college, SIR T Hospital Bhavnagr Gujarat, |
Type of Sponsor |
Government medical college |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Jankiben Panchal |
Government medical college bhavnagar |
anesthesia department pain clinic ,Sir T government hospital bhavnagar 364001 Bhavnagar GUJARAT |
6354517097
panchaljanki222@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
ETHICS COMMITTEE BHAVNAGAR |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: M179||Osteoarthritis of knee, unspecified, (2) ICD-10 Condition: M179||Osteoarthritis of knee, unspecified, (3) ICD-10 Condition: M171||Unilateral primary osteoarthritisof knee, (4) ICD-10 Condition: M171||Unilateral primary osteoarthritisof knee, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
Platelet rich plasma |
patients will receive intraarticular injection of 5ml of platelet rich plasma
Patient receive one injection PRP and follow up for 3 month |
Comparator Agent |
Triamcinolone |
patients will receive intraarticular injection of 40mg triamcinolone + 4ml normal saline patient receive one injection and follow up for 3 months |
|
Inclusion Criteria
|
Age From |
35.00 Year(s) |
Age To |
70.00 Year(s) |
Gender |
Both |
Details |
1)Grades I , II, III Knee OA according to criteria of American college of rheumatology
2)History of chronic pain > 3 month duration
3)Swelling of knee > 4 month
4)X-ray diagnosis ( Kellgren Lawrence 1 and 2)
|
|
ExclusionCriteria |
Details |
1)Knee joint deformities
2)Acute infection
3)H/o knee surgery
4)H/o diabetes mellitus
5)H/o rheumatoid arthritis, gout
H/o severe cardio vascular disorder, 5)haematological disorders, renal disorder
Immunodeficiency
6)Patients taking anticoagulants
7)Patients with haemoglobin values of <10 and platelets values of <1,50,000/mm3
8)H/o vasovagal shock
9)Pregnant and lactating females
10)H/o corticosteroid consumption within last 3 months
|
|
Method of Generating Random Sequence
|
Coin toss, Lottery, toss of dice, shuffling cards etc |
Method of Concealment
|
An Open list of random numbers |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
1)To compare pain decrement by VAS Score ( Visual analogue score).
T2)o compare function and mobility increment and generic health improvement by KOOS score (Knee injury and OA Outcome)(at 6 week)
3)To compare prevention and slowing of the progress of disease by KELLGREN & LAWRENCE Grade (at 3 months ) between two group. |
1)To compare pain decrement by VAS Score ( Visual analogue score).
T2)o compare function and mobility increment and generic health improvement by KOOS score (Knee injury and OA Outcome)(at 6 week)
3)To compare prevention and slowing of the progress of disease by KELLGREN & LAWRENCE Grade (at 3 months ) between two group. |
|
Secondary Outcome
|
Outcome |
TimePoints |
1)To compare analgesic requirement during the study period between two group.
2)To compare need of surgical intervention require during study period Between two group.
|
3 MONTHS |
|
Target Sample Size
|
Total Sample Size="40" Sample Size from India="40"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
28/04/2022 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
NONE |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
After taking approval from ethic committee,study will be initiated on patient fulfilling inclusion criteria ,pt will be assessed for pain decrement by VAS Score ,function and mobility increment and generic health
improvement by KOOS score (Knee
injury and OA Outcome) (at 6 week)&prevention and slowing of the progress of disease by KELLGREN & LAWRENCE Grade (at 3 months ) between two group. |